Sanofi-Aventis S.A. ADR (SNY)

$51.54 0.66 (1.30%)

16:00 EDT SNY Stock Quote Delayed 30 Minutes

The 7 Most Reliable Dividend Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Jun 6, 2023

Faced with a tricky market backdrop, investors may take significant comfort with the most reliable dividend stocks to buy.

7 Blue-Chip Stocks to Buy in May 2023

7 Stock Upgrades and Downgrades Alerts You Cannot Ignore

Why Is Provention Bio (PRVB) Stock Up 263% Today?

Volume:

Previous Close -

Market Cap 64.46B

PE Ratio -

EPS -

Volume (Avg. Vol.) 731,815

Day's Range $51.02 - $51.62

52-Week Range $36.91 - $57.82

Dividend & Yield N/A (N/A)

SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News

From InvestorPlace
From the Web

7 Blue-Chip Stocks to Buy for Quality-Focused Investors

By Josh Enomoto, InvestorPlace Contributor Mar 6, 2023

With circumstances shaky in the market right now, concerned investors may want to consider blue-chip stocks to buy.

Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts

By Samuel O'Brient, InvestorPlace Financial News Writer Jan 31, 2023

One pharmaceutical producer is implementing job cuts. Here's what investors need to know about the Sanofi layoffs.

7 Blue-Chip Stocks to Buy as a New Bull Market Emerges

By Alex Sirois Jan 26, 2023

Many blue-chip stocks look like a bargain right now, and these seven companies are certainly no exception.

Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?

By David Moadel, InvestorPlace Contributor Dec 14, 2022

KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.

SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers

By William White, InvestorPlace Writer Dec 7, 2022

Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker.

7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2022

Those seeking compelling market ideas during this storm may want to consider these relevant under-$50 stocks to buy.

GSK, PFE, SNY Stocks Fall on Zantac Litigation

By David Moadel, InvestorPlace Contributor Aug 11, 2022

You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Aug 11, 2022

Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!

KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket

By William White, InvestorPlace Writer Sep 8, 2021

Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.

3 Best Biotech Stocks To Buy for Upcoming Catalysts

By Muslim Farooque, InvestorPlace Contributor Aug 12, 2021

The next few months are critical for these biotech stocks which could witness a massive increase in their stock prices this year

7 Cheap Value Stocks to Buy for August 2021

By Tezcan Gecgil, InvestorPlace Contributor Jul 27, 2021

These cheap value stocks have the potential to provide shareholders with long-term growth that exceeds their current limiting valuations.

15 European Dividend Aristocrats to Diversify Your Portfolio

By Derek English Jul 21, 2021

Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out.

7 Best Vaccine Stocks for Their Pipeline Potential

By Faisal Humayun, InvestorPlace Contributor Jun 3, 2021

These Covid-19 vaccine stocks may be late in the race, but they certainly have growth potential as we head into the summer.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 3, 2021

We're starting off the week right with a collection of the biggest pre-market stock movers for Monday that investors need to know about.

The Top 7 Pharmaceutical Stocks for the Next 10 Years

By Alex Sirois Jan 11, 2021

Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

6 Cannabis Stocks to Buy as the U.S. Softens Its Stance

By Lou Carlozo, InvestorPlace Contributor Dec 31, 2020

These 6 cannabis stocks show promise in the medical and recreational ends of the burgeoning marijuana sector, set to grow even more in 2021.

The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure

By Tezcan Gecgil, InvestorPlace Contributor Dec 8, 2020

Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

By Bret Kenwell, InvestorPlace Contributor Nov 17, 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Sep 18, 2020

GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

6 Hot Coronavirus Stocks Moving At “Warp Speed”

By Dana Blankenhorn, InvestorPlace Contributor Aug 24, 2020

Even a vaccine that's 50% effective with some side effects would be a game changer. The Trump Administration is throwing billions into that hope and investors are seeing big profits.

Sanofi-Aventis S.A. ADR (SNY)

The 7 Most Reliable Dividend Stocks to Buy Now

7 Blue-Chip Stocks to Buy in May 2023

7 Stock Upgrades and Downgrades Alerts You Cannot Ignore

Why Is Provention Bio (PRVB) Stock Up 263% Today?

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Sanofi-Aventis S.A. ADR (SNY)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News

Subscriber Sign in